All EHA CAR-T Abstracts
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
axicabtagene ciloleucel
Granulocyte colony stimulating factor (GCSF) administration does not affect prevalence and severity of CRS, ICANS nor outcome in patients with R/R large B cells lymphomas treated by CD19 CAR-T
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Multi-technique follow-up of lymphoma patients undergoing commercial CAR-T cell therapy: experience from a single centre
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
TMTV correlates with early progression (EP) after CD19 CAR T-cell therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
An assessment of the reimbursement landscape to CAR T-cell therapy in Europe
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Interim analysis of ZUMA-5: a phase 2 study of axicabtagene ciloleucel (axi-cel) in patients with relapsed/refractory indolent non-hodgkin lymphoma
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Comparison of safety management costs across chimeric antigen receptor (CAR) T cell therapies in relapsed or refractory large B-cell lymphoma
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma – the Munich real life experience
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Tumor microenvironment and elevated IL6 are associated with severe toxicity in patients with LBL treated with axicabtagene ciloleucel
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Outcome of high-grade lymphoma patients treated with CD19 CAR-T – updated real-world experience in the UK
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]